Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M690Revenue $M16.9Net Margin (%)-125.7Z-Score1.6
Enterprise Value $M662EPS $-1.2Operating Margin %-87.2F-Score5
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-125.7Higher ROA y-yY
Price/Book38.710-y EBITDA Growth Rate %-22.8Quick Ratio2.7Cash flow > EarningsY
Price/Sales15.05-y EBITDA Growth Rate %-73.7Current Ratio3.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-63.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-321.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M62.6ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with RPTP

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RPTPJean-Marie Eveillard 2007-06-30 Sold Out $105.78 - $127.38
($117.35)
$ 10.83-91%Sold Out0
RPTPGeorge Soros 2006-03-31 Sold Out $15.14 - $19.73
($17.01)
$ 10.83-36%Sold Out0
RPTPGeorge Soros 2005-09-30 Buy $19.22 - $24.66
($22.11)
$ 10.83-51%New holding, 47700 sh.47,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RPTP is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


RPTP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Anderson RaymondDirector 2014-09-10Sell10,000$10.810.19 view
SAGER ERICHDirector 2014-08-25Sell10,000$11.01-1.63 view
Keltner LlewDirector 2014-07-07Sell10,000$11.21-3.39 view
Anderson RaymondDirector 2014-07-07Sell27,500$11.21-3.39 view
Keltner LlewDirector 2014-05-30Buy100$8.3729.39 view
Erbez GeorgiaCFO 2014-05-13Buy16,100$7.937.09 view
SAMANT VIJAY BDirector 2014-04-07Sell5,000$8.5926.08 view
STARR CHRISTOPHER MCEO 2014-03-17Sell19,316$10.790.37 view
Bruhn Suzanne LouiseDirector 2014-03-13Sell2,760$15.21-28.8 view
Walbert Timothy PDirector 2014-03-13Sell5,521$15.22-28.84 view

Press Releases about RPTP :

    Quarterly/Annual Reports about RPTP:

    News about RPTP:

    Articles On GuruFocus.com
    comment on RPTP Mar 15 2013 

    More From Other Websites
    Raptor Pharmaceutical to Present at Upcoming Investor Conference in September Aug 27 2014
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Aug 21 2014
    RAPTOR PHARMACEUTICAL CORP Financials Aug 15 2014
    Raptor Pharmaceuticals (RPTP) Jumps: Stock Adds 28.2% in Session Aug 11 2014
    Why Raptor Pharmaceuticals (RPTP) Stock Is Gaining Today Aug 08 2014
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition Aug 07 2014
    Raptor Pharmaceutical Reports Second Quarter 2014 Financial Results and Provides Corporate Update Aug 07 2014
    Q2 2014 Raptor Pharmaceutical Corp. Earnings Release - After Market Close Aug 07 2014
    Raptor Pharmaceutical to Present at Upcoming Investor Conference Aug 06 2014
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Other Events Aug 05 2014
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission... Aug 04 2014
    Raptor Receives Orphan Drug Designation for Cysteamine Bitartrate in Huntington's Disease From the... Aug 04 2014
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers Jul 29 2014
    Raptor Pharmaceutical to Hold Second Quarter 2014 Financial Results Webcast and Conference Call Jul 28 2014
    Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic Jul 24 2014
    Long-term calls bullish on Raptor Jul 18 2014
    Raptor Pharmaceuticals CEO to Retire, Appoints Successor Jul 08 2014
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jul 08 2014
    Raptor Pharmaceuticals appoints Julie Anne Smith as president, CEO Jul 07 2014
    Raptor Announces CEO Succession Plan; Dr. Christopher Starr to Retire as CEO at Year-end 2014, Julie... Jul 07 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK